Study highlights difficulty in diagnosing blood disorders, need for coordination between clinicians and pathologists

Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are commonly misdiagnosed—putting patients at increased risk for treatment mistakes and other potentially harmful consequences, according to researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations.